BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11057087)

  • 1. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
    Rogers DF
    COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
    Maestrelli P; Saetta M; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucus hypersecretion in chronic obstructive pulmonary disease.
    Rogers DF
    Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary mucus: Pediatric perspective.
    Rogers DF
    Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
    Hauber HP; Zabel P
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
    Ha EV; Rogers DF
    Pharmacology; 2016; 97(1-2):84-100. PubMed ID: 26674354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoactive drugs for asthma and COPD: any place in therapy?
    Rogers DF
    Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucus and MUC in asthma.
    Morcillo EJ; Cortijo J
    Curr Opin Pulm Med; 2006 Jan; 12(1):1-6. PubMed ID: 16357571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
    Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
    Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-producing elements and inflammatory cells.
    Jeffery P; Zhu J
    Novartis Found Symp; 2002; 248():51-68; discussion 68-75, 277-82. PubMed ID: 12568488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.